Wei Peng Yong

Research interests

Publications

• Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer

  ESMO Open · 2024 · 10.1016/j.esmoop.2023.102226

• Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis

  Journal of Clinical Oncology · 2022 · 10.1200/jco.21.02745

• Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy

  Gastric Cancer · 2022 · 10.1007/s10120-022-01301-0

• Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer

  Cancer Discovery · 2021 · https://doi.org/10.1158/2159-8290.cd-21-0683

• Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study

  Journal of Clinical Oncology · 2021 · 10.1200/jco.20.03555

• Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study

  ˜The œLancet. Gastroenterology & hepatology · 2021 · 10.1016/s2468-1253(21)00196-5

• Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines

  ˜The œLancet. Gastroenterology & hepatology · 2021 · 10.1016/s2468-1253(21)00219-3

• Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids

  Cancer Letters · 2021 · 10.1016/j.canlet.2021.06.007

• Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population

  Gut · 2020 · 10.1136/gutjnl-2020-322065

• A unique CDK4/6 inhibitor: Current and future therapeutic strategies of abemaciclib

  Pharmacological Research · 2020 · 10.1016/j.phrs.2020.104686

• Tweak to Treat: Reprograming Bacteria for Cancer Treatment

  Trends in cancer · 2020 · 10.1016/j.trecan.2020.11.004

• Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer

  Journal of Clinical Oncology · 2018 · 10.1200/jco.2017.76.4381

• An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma

  The Oncologist · 2018 · 10.1634/theoncologist.2018-0838

• PD ‐L1 expression is mainly regulated by interferon gamma associated with JAK ‐ STAT pathway in gastric cancer

  Cancer Science · 2017 · 10.1111/cas.13424

• Phase I/II study of durvalumab and tremelimumab in patients with unresectable hepatocellular carcinoma (HCC): Phase I safety and efficacy analyses.

  Journal of Clinical Oncology · 2017 · 10.1200/jco.2017.35.15_suppl.4073

• Chemotherapy for advanced gastric cancer

  Cochrane Database of Systematic Reviews · 2017 · https://doi.org/10.1002/14651858.cd004064.pub4

• Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas

  Gut · 2014 · 10.1136/gutjnl-2014-308252

• Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer

  Gut · 2012 · 10.1136/gutjnl-2011-301113

• Methylation Subtypes and Large-Scale Epigenetic Alterations in Gastric Cancer

  Science Translational Medicine · 2012 · 10.1126/scitranslmed.3004504

• Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial

  Journal of Clinical Oncology · 2012 · 10.1200/jco.2011.39.9824

• A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets

  Gut · 2012 · https://doi.org/10.1136/gutjnl-2011-301839

• Sequential expression of putative stem cell markers in gastric carcinogenesis

  British Journal of Cancer · 2011 · 10.1038/bjc.2011.287

• Intrinsic Subtypes of Gastric Cancer, Based on Gene Expression Pattern, Predict Survival and Respond Differently to Chemotherapy

  Gastroenterology · 2011 · 10.1053/j.gastro.2011.04.042

• Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study

  Journal of Clinical Oncology · 2010 · 10.1200/jco.2010.28.4075

• Clinical pharmacology and pharmacogenetics of gemcitabine

  Drug Metabolism Reviews · 2009 · 10.1080/03602530902741828

Current projects

No projects listed.